title: Soft Elasticity-Associated Signaling and Bone Morphogenic Protein 2 Are Key Regulators of Mesenchymal Stem Cell Spheroidal Aggregates.
abstract: Cell therapy with adult mesenchymal stem cells (MSCs) is a promising approach to regenerative medicine and autoimmune diseases. There are various approaches to improve the efficacy of MSC-based therapeutics, and MSC preparation as spheroidal aggregates, or MSC spheroids, is a novel preparatory and delivery method. Spheroid formation induces a dramatic change in the gene expression profile of MSCs. Self-activation of interleukin-1 (IL1) signaling was shown to be upstream of both pro- and anti-inflammatory genes in MSC spheroids, but the molecular pathways that initiate IL1 signaling remain unknown. As bone morphogenic protein (BMP)2 upregulation precedes that of IL1B expression during spheroid formation, we hypothesized that BMP2 signaling triggers IL1 signaling in MSC spheroids. Contrary to expectations, BMP2 signaling decreased expression of IL1B and downstream genes in a SMAD6-dependent manner. Conversely, IL1B signaling enhanced BMP2 expression. Another major difference between two-dimensional (2D) monolayer culture and three-dimensional (3D) spheroid culture is the Young's elasticity modulus, or stiffness, of the materials surrounding the cells, as there is a million-fold difference between a plastic surface for standard 2D culture (GPa) and 3D spheroidal aggregates (0.1 kPa). We tested another hypothesis that soft elasticity-associated mechano-signaling initiates the gene expression change during spheroid formation. Results showed that both BMP2 expression and inflammatory signaling are upregulated in an elasticity-associated signaling-dependent manner in MSCs. Lastly, BMP2 signaling enhanced cell survival and cell spreading of MSC spheroids. In summary, our study suggests that soft elasticity and BMP2 signaling are critical for MSC spheroids.
authors.affiliation: 1 Department of Pathology, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania.
authors.forename: Zoe
authors.initials: Z
authors.lastname: Cesarz
authors.affiliation: 1 Department of Pathology, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania.
authors.forename: Jessica L
authors.initials: JL
authors.lastname: Funnell
authors.affiliation: 2 Department of Materials Science and Engineering, the Ohio State University , Columbus, Ohio.
authors.forename: Jianjun
authors.initials: J
authors.lastname: Guan
authors.affiliation: 1 Department of Pathology, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania.|3 McGowan Institute for Regenerative Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania.
authors.forename: Kenichi
authors.initials: K
authors.lastname: Tamama
mesh_terms: D055396:Bone Morphogenetic Protein 2 / Q000502:physiology*; D002449:Cell Aggregation; D002470:Cell Survival; D002478:Cells, Cultured; D003470:Culture Media; D004548:Elasticity; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D053583:Interleukin-1beta / Q000502:physiology; D040542:Mechanotransduction, Cellular; D059630:Mesenchymal Stem Cells / Q000378:metabolism*; D018874:Spheroids, Cellular / Q000378:metabolism; D059467:Transcriptome
chemical_list: C525718:BMP2 protein, human; D055396:Bone Morphogenetic Protein 2; D003470:Culture Media; D018836:Inflammation Mediators; D053583:Interleukin-1beta